AbbVie Inc.
ABBVNYSEHealthcare● Active
$227.23
+$2.29(+1.02%)
Market Cap$401.5B
P/E Ratio—
52W High$244.81
52W Low$181.73
AbbVie Inc. (ABBV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABBV · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $61.16B | $56.33B | $54.32B | $58.05B | $56.20B |
| Cost of Revenue | $18.20B | $16.90B | $20.41B | $17.41B | $17.45B |
| Gross Profit | $42.96B | $39.43B | $33.90B | $40.64B | $38.75B |
| Gross Margin %(computed) | 70.24% | 69.99% | 62.42% | 70.00% | 68.96% |
| Operating Expenses | |||||
| R&D Expenses | $9.10B | $12.79B | $7.67B | $6.51B | $8.05B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $22.86B | $30.29B | $21.15B | $22.52B | $20.83B |
| Operating Income | $20.09B | $9.14B | $12.76B | $18.12B | $17.92B |
| Operating Margin %(computed) | 32.85% | 16.22% | 23.49% | 31.21% | 31.89% |
| Interest Income | $0.27B | $0.65B | $0.54B | $0.19B | $0.04B |
| Interest Expense | $2.89B | $2.81B | $2.22B | $2.23B | $2.42B |
| Income Before Tax | $6.60B | $3.72B | $6.25B | $13.48B | $12.99B |
| Income Tax Expense | $2.36B | ($0.57B) | $1.38B | $1.63B | $1.44B |
| Net Income | $4.23B | $4.28B | $4.86B | $11.84B | $11.54B |
| Net Margin %(computed) | 6.91% | 7.59% | 8.95% | 20.39% | 20.54% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.37 | $2.40 | $2.73 | $6.65 | $6.48 |
| Wtd Avg Shares | 1.78B | 1.77B | 1.77B | 1.77B | 1.77B |
| EBITDA | $17.63B | $14.91B | $17.17B | $24.17B | $23.93B |
| EBITDA Margin %(computed) | 28.82% | 26.47% | 31.61% | 41.64% | 42.59% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more AbbVie Inc. data
About AbbVie Inc. (ABBV) Income Statement
AbbVie Inc. (ABBV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ABBV reported revenue of $61.16B, gross profit of $42.96B (gross margin 70.24%), and net income of $4.23B — a net profit margin of 6.91%.
Frequently asked questions
ABBV · 4 questionsAbbVie Inc. (ABBV) reported revenue of $61.16B for 2025, up 8.6% year-over-year.
ABBV revenueABBV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08